The ESRC Innogen Centre investigates the far-reaching impacts of the new life sciences.
Breakthroughs in the life sciences often make headlines around the world: from GM crops, cloned sheep and stem cells to DNA databases, new medicines and biofuels.
These discoveries have the potential to transform our lives and Innogen, the ESRC Centre for Social and Economic Research on Innovation in Genomics, was established to investigate the far-reaching social, ethical and economic impact of the new life sciences.
We have achieved a wide range of successes including excellent results in the 2008 RAE.
Professor David Wield
Innogen Centre Director
Innogen has an international perspective on the life sciences with a distinctive focus on globalisation and particular expertise in empirical research on life-science-based innovation in Africa, India and China in addition to Europe and the USA.
Taking a closer look at the pharmaceutical and biotechnology industries, we analyse life science innovation at regional, national and international levels from small start-ups to multinational companies to discover how good ideas in the life sciences can be turned into real-life solutions.
We also investigate how these new developments are regulated and ask whether and how radical change in regulatory systems could deliver more public benefits faster, while ensuring that the public have the opportunity to voice any concerns about new technology.
“Innogen’s research programme provides a sound base for decision-making in science, industry, policy and public arenas. This programme continues to expand and we have achieved a wide range of successes including excellent results in the 2008 RAE” says Centre Director, Professor David Wield.
“Our research has been taken up by a wide range of agencies. The OECD commissioned a report from us on the pharmaceutical industry which was presented to a major meeting in Paris of OECD country and industry representatives. This report also formed the basis for a private meeting with the Vice-Presidents for Regulatory Affairs from three major pharmaceutical companies who complimented us on the accuracy of our analysis and sought further advice on their future innovation strategies.”
Innogen was formed in October 2002 with core funding from the Economic and Social Research Council (ESRC). The centre is based within the School of Social and Political Science at the University of Edinburgh and within the Development Policy and Practice Department at The Open University.
Innogen is part of the ESRC Genomics Network, one of the largest social science investments in the ESRC's current portfolio, and is growing into the largest concentration of social scientific research on genomics in the world.
To reflect our inter- and multi-disciplinary aims, the researchers working at Innogen include social scientists, economists, and lawyers. Innogen also engages with a wide range of stakeholders, nationally and internationally, including scientists, industry and private interest groups, policymakers and regulators, and citizens and public interest groups.
For additional information about the ESRC Innogen Centre, please visit our website:
Alternatively you can contact our Communications and Policy Officer Jen Foley.
This article was published on Jun 1, 2011